Literature DB >> 6230451

Early proliferative response in the human autologous mixed lymphocyte reaction in scleroderma.

J Alcocer-Varela, A Laffón, D Alarcón-Segovia, G Ibañez de Kasep.   

Abstract

Autologous mixed lymphocyte reaction (AMLR) studied at 7 days with cells from 20 scleroderma patients appeared decreased as compared to healthy matched controls. In kinetic AMLR studies with cells from 16 patients, this was found to result from the decline after an early proliferative response occurring on Day 4 (9 patients) or 5 (4 patients), whereas the other 2 had low responses throughout. As this early response may be anamnestic, kinetic studies lasting 12 days revealed a second proliferative response on the 9th or 10th day and the responses in allogeneic mixed lymphocyte cultures did not differ from those found in normal controls. These findings suggest either that autoreactivity between T and non T cells might have occurred in vivo in scleroderma patients and is recalled in the AMLR or that alterations of immunoregulatory cells permit this earlier activation in the system.

Entities:  

Mesh:

Year:  1984        PMID: 6230451

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  2 in total

1.  Abnormalities of T lymphocyte subsets in systemic sclerosis demonstrated with anti-CD45RA and anti-CD29 monoclonal antibodies.

Authors:  A Kahan; A Kahan; F Picard; C J Menkès; B Amor
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

2.  Enhanced production of transforming growth factor-beta (TGF-beta) during autologous mixed lymphocyte reaction of systemic sclerosis patients.

Authors:  H Ota; S Kumagai; A Morinobu; H Yanagida; K Nakao
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.